STI-571治疗慢性粒细胞白血病 - Suppr

Suppr

超能文献

STI-571 in chronic myelogenous leukaemia.

作者信息

Tsao Anne S, Kantarijian Hagop, Talpaz Moshe

机构信息

Department of Bioimmunotherapy, M D Anderson Cancer Center, Houston, TX, USA.

出版信息

Br J Haematol. 2002 Oct;119(1):15-24. doi: 10.1046/j.1365-2141.2002.03899.x.

DOI:10.1046/j.1365-2141.2002.03899.x

PMID:12358949

Abstract

摘要

相似文献

STI-571 in chronic myelogenous leukaemia.

Br J Haematol. 2002 Oct;119(1):15-24. doi: 10.1046/j.1365-2141.2002.03899.x.

Imatinib mesylate: a new pill for chronic myelogenous leukemia.

Cancer Pract. 2001 Sep-Oct;9(5):263-5. doi: 10.1046/j.1523-5394.2001.95003.x.

After imatinib: new hopes for chronic myeloid leukaemia.

Drug Discov Today. 2005 Apr 15;10(8):536-7. doi: 10.1016/S1359-6446(05)03422-7.

Cross-resistance of imatinib mesylate and 17-AAG in imatinib-resistant cells that overexpress BCR-ABL.

Br J Haematol. 2003 May;121(4):672-3. doi: 10.1046/j.1365-2141.2003.04330.x.

3. Imatinib therapy in chronic myelogenous leukemia.

Intern Med. 2007;46(2):95-7. doi: 10.2169/internalmedicine.46.1781. Epub 2007 Jan 15.

Imatinib mesylate noncompliance simulating chronic myeloid leukemia resistance.

J Pediatr Hematol Oncol. 2003 Jun;25(6):507-8. doi: 10.1097/00043426-200306000-00017.

Position paper on imatinib mesylate in chronic myeloid leukaemia.

Br J Haematol. 2002 Oct;119(1):268-72. doi: 10.1046/j.1365-2141.2002.39201.x.

NICE widens patient group for leukaemia drug.

BMJ. 2002 Oct 19;325(7369):852. doi: 10.1136/bmj.325.7369.852/a.

Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?

Leuk Lymphoma. 2008 Jun;49(6):1022-3. doi: 10.1080/10428190802074635.

New directions in the treatment of patients with chronic myeloid leukemia: introduction.

Semin Hematol. 2009 Apr;46(2 Suppl 3):S1-4. doi: 10.1053/j.seminhematol.2009.01.006.

引用本文的文献

Protein Kinases in Hematological Disorders.

Adv Exp Med Biol. 2021;1275:383-393. doi: 10.1007/978-3-030-49844-3_15.

Tyrosine kinase inhibitors and pregnancy.

Mediterr J Hematol Infect Dis. 2014 Apr 7;6(1):e2014028. doi: 10.4084/MJHID.2014.028. eCollection 2014.

Chronic Myeloid Leukaemia in The 21st Century.

Ulster Med J. 2007 Jan;76(1):8-17.

Blastic phase of chronic myelogenous leukemia.

Curr Treat Options Oncol. 2006 May;7(3):189-99. doi: 10.1007/s11864-006-0012-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

STI-571 in chronic myelogenous leukaemia.

Br J Haematol. 2002 Oct;119(1):15-24. doi: 10.1046/j.1365-2141.2002.03899.x.

Imatinib mesylate: a new pill for chronic myelogenous leukemia.

Cancer Pract. 2001 Sep-Oct;9(5):263-5. doi: 10.1046/j.1523-5394.2001.95003.x.

After imatinib: new hopes for chronic myeloid leukaemia.

Drug Discov Today. 2005 Apr 15;10(8):536-7. doi: 10.1016/S1359-6446(05)03422-7.

Cross-resistance of imatinib mesylate and 17-AAG in imatinib-resistant cells that overexpress BCR-ABL.

Br J Haematol. 2003 May;121(4):672-3. doi: 10.1046/j.1365-2141.2003.04330.x.

3. Imatinib therapy in chronic myelogenous leukemia.

Intern Med. 2007;46(2):95-7. doi: 10.2169/internalmedicine.46.1781. Epub 2007 Jan 15.

Imatinib mesylate noncompliance simulating chronic myeloid leukemia resistance.

J Pediatr Hematol Oncol. 2003 Jun;25(6):507-8. doi: 10.1097/00043426-200306000-00017.

Position paper on imatinib mesylate in chronic myeloid leukaemia.

Br J Haematol. 2002 Oct;119(1):268-72. doi: 10.1046/j.1365-2141.2002.39201.x.

NICE widens patient group for leukaemia drug.

BMJ. 2002 Oct 19;325(7369):852. doi: 10.1136/bmj.325.7369.852/a.

Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?

Leuk Lymphoma. 2008 Jun;49(6):1022-3. doi: 10.1080/10428190802074635.

New directions in the treatment of patients with chronic myeloid leukemia: introduction.

Semin Hematol. 2009 Apr;46(2 Suppl 3):S1-4. doi: 10.1053/j.seminhematol.2009.01.006.

引用本文的文献

Protein Kinases in Hematological Disorders.

Adv Exp Med Biol. 2021;1275:383-393. doi: 10.1007/978-3-030-49844-3_15.

Tyrosine kinase inhibitors and pregnancy.

Mediterr J Hematol Infect Dis. 2014 Apr 7;6(1):e2014028. doi: 10.4084/MJHID.2014.028. eCollection 2014.

Chronic Myeloid Leukaemia in The 21st Century.

Ulster Med J. 2007 Jan;76(1):8-17.

Blastic phase of chronic myelogenous leukemia.

Curr Treat Options Oncol. 2006 May;7(3):189-99. doi: 10.1007/s11864-006-0012-y.